×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MDXG – mimedx group, inc (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MDXG
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/22
10:36 am
mdxg
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel [Yahoo! Finance]
Low
Report
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel [Yahoo! Finance]
12/22
09:43 am
mdxg
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel
Low
Report
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel
12/20
08:22 am
mdxg
With 47% stake, MiMedx Group, Inc. (NASDAQ:MDXG) seems to have captured institutional investors' interest [Yahoo! Finance]
Low
Report
With 47% stake, MiMedx Group, Inc. (NASDAQ:MDXG) seems to have captured institutional investors' interest [Yahoo! Finance]
12/19
10:09 am
mdxg
MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro [Yahoo! Finance]
Low
Report
MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro [Yahoo! Finance]
12/19
09:00 am
mdxg
MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro
Low
Report
MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro
12/17
08:24 am
mdxg
MiMedx Group (NASDAQ:MDXG) had its price target lowered by analysts at Mizuho from $12.00 to $10.00. They now have an "outperform" rating on the stock.
Low
Report
MiMedx Group (NASDAQ:MDXG) had its price target lowered by analysts at Mizuho from $12.00 to $10.00. They now have an "outperform" rating on the stock.
12/17
03:51 am
mdxg
?????????? - ??????????????????2026-2035? [CNET News]
Low
Report
?????????? - ??????????????????2026-2035? [CNET News]
11/17
01:42 pm
mdxg
MiMedx (MDXG) Just Flashed Golden Cross Signal: Do You Buy? [Yahoo! Finance]
Low
Report
MiMedx (MDXG) Just Flashed Golden Cross Signal: Do You Buy? [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
11/10
05:15 pm
mdxg
Form 4 MIMEDX GROUP, INC. For: Nov 06 Filed by: Maersk-Moller Kimberly
Low
Report
Form 4 MIMEDX GROUP, INC. For: Nov 06 Filed by: Maersk-Moller Kimberly
11/6
04:14 pm
mdxg
Form 144 MIMEDX GROUP, INC. Filed by: Maersk-Moller Kimberly
Medium
Report
Form 144 MIMEDX GROUP, INC. Filed by: Maersk-Moller Kimberly
10/29
04:08 pm
mdxg
Form 8-K MIMEDX GROUP, INC. For: Oct 29
Low
Report
Form 8-K MIMEDX GROUP, INC. For: Oct 29
10/29
04:01 pm
mdxg
Form 10-Q MIMEDX GROUP, INC. For: Sep 30
Low
Report
Form 10-Q MIMEDX GROUP, INC. For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
5/30
Form 8-K MIMEDX GROUP, INC. For: May 30
35.6%
9/21 MiMedx to treat executive terminations as "for cause" - shares down 11% premarket [Seeking Alpha] 19.4%
5/31 Form DFAN14A MIMEDX GROUP, INC. Filed by: PETIT PARKER H 18.5%
1/8 Prescience Point Capital Management Issues Positive Report on MiMedx Group Inc. (OTC: MDXG) 15.3%
10/30 Form 4 MIMEDX GROUP, INC. For: Oct 26 Filed by: Haden Alexandra O 11.7%
12/7 Form SC 13G/A MIMEDX GROUP, INC. Filed by: BlackRock Inc. 10.4%
8/31 Form 8-K MIMEDX GROUP, INC. For: Aug 31 7.9%
8/13 MiMedx announces Nasdaq listing extension and Hearing Date 7.5%
8/16 Why Dillard's, MiMedx Group, and Global Net Lease Slumped Today [The Motley Fool] 6.2%
8/24 MiMedx Announces Statistically Significant Results In New Multicenter Clinical Study Of Healing Of Diabetic Foot Ulcers Using EpiFix® 6.0%
9/21 MiMedx to treat executive terminations as "for cause" - shares down 11% premarket [Seeking Alpha] 19.4%
5/31 Form DFAN14A MIMEDX GROUP, INC. Filed by: PETIT PARKER H 18.5%
1/8 Prescience Point Capital Management Issues Positive Report on MiMedx Group Inc. (OTC: MDXG) 15.3%
10/30 Form 4 MIMEDX GROUP, INC. For: Oct 26 Filed by: Haden Alexandra O 11.7%
12/7 Form SC 13G/A MIMEDX GROUP, INC. Filed by: BlackRock Inc. 10.4%
8/31 Form 8-K MIMEDX GROUP, INC. For: Aug 31 7.9%
8/13 MiMedx announces Nasdaq listing extension and Hearing Date 7.5%
8/16 Why Dillard's, MiMedx Group, and Global Net Lease Slumped Today [The Motley Fool] 6.2%
8/24 MiMedx Announces Statistically Significant Results In New Multicenter Clinical Study Of Healing Of Diabetic Foot Ulcers Using EpiFix® 6.0%
TOP News Decliners
12/5
MiMedx Announces Leadership Changes And Promotions
-59.3%
11/7 MiMedx Receives Nasdaq Delisting Notification -39.3%
11/7 Form 8-K MIMEDX GROUP, INC. For: Nov 06 -20.5%
9/21 MiMedx breaks out, up 28% [Seeking Alpha] -19.5%
7/26 MiMedx Announces Receipt of Nasdaq Letter -16.0%
10/4 Form 8-K MIMEDX GROUP, INC. For: Oct 03 -12.3%
8/13 MiMedx files to delay 10-Q [Seeking Alpha] -11.1%
8/24 MiMedx's EpiFix shows effectiveness in healing diabetic foot ulcers; shares up 7% premarket [Seeking Alpha] -9.9%
12/13 Form 3 MIMEDX GROUP, INC. For: Dec 05 Filed by: Turner Scott M -9.9%
6/4 Form DEFA14A MIMEDX GROUP, INC. -9.7%
11/7 MiMedx Receives Nasdaq Delisting Notification -39.3%
11/7 Form 8-K MIMEDX GROUP, INC. For: Nov 06 -20.5%
9/21 MiMedx breaks out, up 28% [Seeking Alpha] -19.5%
7/26 MiMedx Announces Receipt of Nasdaq Letter -16.0%
10/4 Form 8-K MIMEDX GROUP, INC. For: Oct 03 -12.3%
8/13 MiMedx files to delay 10-Q [Seeking Alpha] -11.1%
8/24 MiMedx's EpiFix shows effectiveness in healing diabetic foot ulcers; shares up 7% premarket [Seeking Alpha] -9.9%
12/13 Form 3 MIMEDX GROUP, INC. For: Dec 05 Filed by: Turner Scott M -9.9%
6/4 Form DEFA14A MIMEDX GROUP, INC. -9.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: